Log in

SANUWAVE Health Stock Forecast, Price & News

+0.01 (+4.76 %)
(As of 09/28/2020 12:00 AM ET)
Today's Range
Now: $0.22
50-Day Range
MA: $0.23
52-Week Range
Now: $0.22
Volume318,254 shs
Average Volume309,908 shs
Market Capitalization$71.86 million
P/E RatioN/A
Dividend YieldN/A
SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications worldwide. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolOTCMKTS:SNWV



Sales & Book Value

Annual Sales$1.03 million
Book Value($0.03) per share


Net Income$-10,430,000.00
Net Margins-1,583.12%


Market Cap$71.86 million
Next Earnings Date11/20/2020 (Estimated)
OptionableNot Optionable
+0.01 (+4.76 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SNWV News and Ratings via Email

Sign-up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions

How has SANUWAVE Health's stock been impacted by Coronavirus?

SANUWAVE Health's stock was trading at $0.27 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SNWV stock has decreased by 18.5% and is now trading at $0.22.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of SANUWAVE Health?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SANUWAVE Health in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for SANUWAVE Health

When is SANUWAVE Health's next earnings date?

SANUWAVE Health is scheduled to release its next quarterly earnings announcement on Friday, November 20th 2020.
View our earnings forecast for SANUWAVE Health

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) issued its quarterly earnings results on Friday, August, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.08 million for the quarter.
View SANUWAVE Health's earnings history

What price target have analysts set for SNWV?

1 analysts have issued twelve-month target prices for SANUWAVE Health's stock. Their forecasts range from $0.34 to $0.34. On average, they expect SANUWAVE Health's stock price to reach $0.34 in the next twelve months. This suggests a possible upside of 54.5% from the stock's current price.
View analysts' price targets for SANUWAVE Health

Are investors shorting SANUWAVE Health?

SANUWAVE Health saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,290,700 shares, an increase of 37.0% from the August 15th total of 941,800 shares. Based on an average trading volume of 732,800 shares, the short-interest ratio is presently 1.8 days.
View SANUWAVE Health's Short Interest

Who are some of SANUWAVE Health's key competitors?

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SANUWAVE Health investors own include Co-Diagnostics (CODX), Ibio (IBIO), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Onconova Therapeutics (ONTX), Digital Ally (DGLY), Inpixon (INPX), Biocept (BIOC), FuelCell Energy (FCEL) and Kopin (KOPN).

Who are SANUWAVE Health's key executives?

SANUWAVE Health's management team includes the following people:
  • Mr. Kevin A. Richardson II, Chairman & CEO (Age 51)
  • Mr. Shri P. Parikh, Pres (Age 47)
  • Ms. Lisa E. Sundstrom, Chief Financial Officer (Age 50)
  • Mr. Peter Stegagno, Chief Operating Officer (Age 59)
  • Dr. Iulian Cioanta, Chief Science & Technology Officer (Age 56)

What is SANUWAVE Health's stock symbol?

SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."

How do I buy shares of SANUWAVE Health?

Shares of SNWV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SANUWAVE Health's stock price today?

One share of SNWV stock can currently be purchased for approximately $0.22.

How big of a company is SANUWAVE Health?

SANUWAVE Health has a market capitalization of $71.86 million and generates $1.03 million in revenue each year. SANUWAVE Health employs 14 workers across the globe.

What is SANUWAVE Health's official website?

The official website for SANUWAVE Health is www.sanuwave.com.

How can I contact SANUWAVE Health?

SANUWAVE Health's mailing address is 3360 Martin Farm Road Suite 100, Suwanee GA, 30024. The company can be reached via phone at 770-419-7525 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.